Regenerative Medicine Institute (RMI) of Tijuana, Mexico is the first clinic participant in the recently launched ICMS Stem Cell Clinic Accreditation Program.

RMI is based out of Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital. The clinic claims to provide high quality chronic disease treatments centered around patient dignity and safety.· Its medical team of board certified specialists provides adipose-derived stem cell therapies to patients. Under its agreement with the ICMS, RMI will provide an unprecedented level of transparency into its clinical and medical practices. All treatment protocols, as well as patient informed consent and patient candidacy documentation will be reviewed by the institutional review board of the ICMS.

As part of the accreditation process, the ICMS will be investigating every aspect of the clinics practices, processes, and protocols.  RMI’s patient candidacy protocols, informed consent process, and cell collection, processing, and implantation practices will all be examined for compliance with the ICMS Best Practice Guidelines.  To read the full press release click HERE.